explore -WSS

explore

author：leisure time 2025-09-27 23:53:59 - browse：574

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： HHS secretary Becerra pressed on Change HealthCare cyberattack

knowledge

WSS

Court strikes down limits on filming of police in Arizona

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Caitlin Bernard's story shows physicians can't shy from advocacy

Providers still hesitate to prescribe buprenorphine, study finds

Body of missing toddler recovered in Delaware River days after flood: Police

New rules on organ donation and transplantation 'will bring chaos'

leisure time

explore

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

A double vaccine crisis is endangering millions of children

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Guidelines to prevent youth baseball injuries need more muscle

White House launches permanent pandemic office

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Pushing for an NIH office for post

Psychedelics group wrestles with new pharma identity

Court strikes down limits on filming of police in Arizona

focus

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Readout Newsletter: CAR

Ebola: Gilead Sciences antiviral shows promise as new treatment

EPA limits use of carcinogenic gas for sterilizing medical devices

Change Healthcare outage fallout shows need for new oversight

HIPAA doesn't protect reproductive records from prosecutors

focus

focus

knowledge

focus